The landscape of blood sugar treatment is changing with the introduction of skin-applied GLP-1 therapy. These innovative devices offer a likely simpler alternative to shots for individuals living with type 2 diabetes . They deliver a GLP-1 agonist directly through the epidermis, bypassing the req